Valley National Advisers’s HUMANIGEN, INC. HGEN Stock Holding History

Valley National Advisers’s Portfolio HGEN Stock Details HGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-4	Closed	-$1K	–	1146
2023 Q2	$1K	Hold	4	–	–	﹤0.01%	973
2023 Q1	$0	Hold	4	–	–	﹤0.01%	1001
2022 Q4	$0	Hold	4	–	–	﹤0.01%	1014
2022 Q3	$0	Hold	4	–	–	﹤0.01%	1022
2022 Q2	$0	Hold	4	–	–	﹤0.01%	999
2022 Q1	$0	Hold	4	–	–	﹤0.01%	1006
2021 Q4	$0	Hold	4	–	–	﹤0.01%	986
2021 Q3	$0	Hold	4	–	–	﹤0.01%	962
2021 Q2	$0	Hold	4	–	–	﹤0.01%	952
2021 Q1	$0	Hold	4	–	–	﹤0.01%	926
2020 Q4	$0	Hold	4	–	–	﹤0.01%	873
2020 Q3	$0	Buy	+4	New	+$41	﹤0.01%	856

Other funds holding HGEN

TCM

Triumph Capital Management Denver, Colorado $552M AUM 20.75% 1-Year Est. Return

DWP

Daymark Wealth Partners Cincinnati, Ohio $3.18B AUM 23.46% 1-Year Est. Return

CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return

Valley National Advisers's HGEN Position: Q3 2023 in Review

Valley National Advisers sold out of HUMANIGEN, INC. (HGEN) in Q3 2023, closing a stake of 4 shares — an estimated $1K sold.

Valley National Advisers first reported a position in HGEN in Q3 2020 and held it in 12 quarters. The position peaked at $1K in Q2 2023. 3 funds tracked by Wall St. Rank hold HGEN as of Q3 2023.

Valley National Advisers reported no remaining HUMANIGEN, INC. position as of Q3 2023 after selling out during the quarter.
Valley National Advisers sold 4 HUMANIGEN, INC. shares in Q3 2023, an estimated $1K.
Valley National Advisers first reported a position in HUMANIGEN, INC. in Q3 2020 and held it in 12 quarters.
Valley National Advisers's HUMANIGEN, INC. position peaked at $1K in Q2 2023.
3 funds tracked by Wall St. Rank held HUMANIGEN, INC. as of Q3 2023.

Based on Valley National Advisers's 13F filing for Q3 2023, filed 13 Nov 2023.